Stocks
QuidelOrtho CorporationQDEL
NASDAQHealthcareDiagnostics & Research$17.10-4.58%
Specializing in diagnostic testing solutions, this company develops and manufactures rapid point-of-care and lab-based tests for infectious diseases, cardiovascular conditions, and more. Investors monitor its performance due to its role in pandemic response and the growing demand for decentralized diagnostics. Its product portfolio includes lateral flow assays, molecular diagnostics, and immunoassay systems.
Market Cap: $1.2B52W Range: $17.08 – $38.99
Congressional Interest in QuidelOrtho Corporation (QDEL)
7 members of Congress have disclosed 20 trades in QuidelOrtho Corporation (QDEL), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 14 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
20
Unique Politicians
7
Buys
6
Sells
14
Who in Congress Is Trading QDEL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-19 | Byron Donalds | sell | $1K – $15K |
| 2023-10-19 | Byron Donalds | sell | $1K – $15K |